Victory Capital Management
TCRT icon

Victory Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Victory Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-167
Closed -$3.31K – 2640
2023
Q3 		$3.31K Buy
167
+9
+6% +$388 ﹤0.01% 2509
2023
Q2 		$12.1K Sell
158
-4
-2% -$324 ﹤0.01% 2480
2023
Q1 		$15.3K Sell
162
-2
-1% -$190 ﹤0.01% 2526
2022
Q4 		$15.9K Buy
164
+17
+12% +$2.46K ﹤0.01% 2523
2022
Q3 		$38K Sell
147
-27
-16% -$7.84K ﹤0.01% 2585
2022
Q2 		$32K Sell
174
-1
-0.6% -$96 ﹤0.01% 2585
2022
Q1 		$14K Sell
175
-5
-3% -$642 ﹤0.01% 2657
2021
Q4 		$29K Sell
180
-5
-3% -$1.1K ﹤0.01% 2671
2021
Q3 		$51K Buy
185
+4
+2% +$1.22K ﹤0.01% 2686
2021
Q2 		$72K Sell
181
-3
-2% -$1.4K ﹤0.01% 2640
2021
Q1 		$99K Sell
184
-10
-5% -$6.23K ﹤0.01% 2607
2020
Q4 		$73K Buy
194
+10
+5% +$3.98K ﹤0.01% 2438
2020
Q3 		$69K Sell
184
-11
-6% -$4.86K ﹤0.01% 2371
2020
Q2 		$96K Sell
195
-208
-52% -$92.7K ﹤0.01% 2360
2020
Q1 		$148K Buy
403
+39
+11% +$20.2K ﹤0.01% 2417
2019
Q4 		$257K Buy
364
+131
+56% +$90.2K ﹤0.01% 2250
2019
Q3 		$149K Buy
+233
New +$185K ﹤0.01% 2309

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Victory Capital Management's TCRT Position: Q4 2023 in Review

Victory Capital Management sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 167 shares — an estimated $3.31K sold.

Victory Capital Management first reported a position in TCRT in Q3 2019 and held it in 17 quarters. The position peaked at $257K in Q4 2019. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Victory Capital Management reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 167 Alaunos Therapeutics shares in Q4 2023, an estimated $3.31K.
  • Victory Capital Management first reported a position in Alaunos Therapeutics in Q3 2019 and held it in 17 quarters.
  • Victory Capital Management's Alaunos Therapeutics position peaked at $257K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.